OncoTracking™ monitors patients for early signs
of cancer recurrence
Whether a patient is in remission or is currently undergoing treatment.
The sooner cancer recurrence or metastasis is found, the sooner the patient can receive appropriate therapy and treatment.
That’s why we’ve created OncoTracking™ — a testing program that monitors your blood for your specific type of cancer to detect recurrence sooner than traditional tests such as CT scans or MRIs.